Singh will develop a medical decision making guide for African-American and Hispanic lupus patients with kidney disease.
S. Louis Bridges Jr., M.D., Ph.D., will succeed Robert P. Kimberly, M.D., as director of the Comprehensive Arthritis, Musculoskeletal & Autoimmunity Center.
Researchers show long-term efficacy of the first FDA approved drug for vasculitis.
Leading immunologists, including a Nobel winner and a Lasker Prize awardee, gathered at the UAB campus in June for the second annual Spring Immunology Symposium.
Researchers are launching a study to look at the links between sleep and pain in patients with knee osteoarthritis.
Tomana retired as a research professor of medicine in the Division of Clinical Immunology and Rheumatology in July 1997 after working almost 40 years at UAB.
Patients with rheumatoid arthritis have an increased risk for shingles, but new research at UAB indicates that biologics – the newest RA medications – don’t worsen that risk.
Kenneth Saag, M.D., co-authored a review of five tests and treatments used in rheumatology that should be questioned and discussed between doctors and patients.
A new round of grand funding will allow researchers to study the HIV and tuberculosis epidemics.
Genetic changes that protected their ancestors against fly-borne parasites may partly explain why African-Americans with lupus are up to five times more likely to develop end-stage kidney disease than those of European descent. This was the conclusion of a study presented this week at the American College of Rheumatology Scientific Sessions in Washington, D.C.